Related Experiment Video
Updated: May 4, 2026
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
New avenues for treatment of intracranial hemorrhage
Shruti Sonni1, Vasileios-Arsenios Lioutas, Magdy H Selim
1Department of Neurology, Cambridge Hospital, 1493 Cambridge Street, Cambridge, MA, 02139, USA, ssonni@challiance.org.
Insights
Intracerebral hemorrhage (ICH) treatment remains challenging, but new therapies are emerging. Advances in minimally invasive surgery, advanced imaging, and targeted drug development offer hope for reducing high mortality and morbidity rates.
Area of Science:
- Neurology
- Neurosurgery
- Emergency Medicine
Background:
- Intracerebral hemorrhage (ICH) continues to cause high mortality and morbidity.
- Despite recent advances in medical, neurologic, and surgical care, effective treatments for ICH remain limited.
Purpose of the Study:
- To review emerging therapeutic strategies for intracerebral hemorrhage.
- To highlight potential advancements in surgical techniques, diagnostic imaging, and pharmacologic interventions.
Main Methods:
- Review of recent therapeutic trials and pathophysiological understanding of ICH.
- Analysis of advancements in imaging and pre-hospital assessment.
- Exploration of novel drug targets for secondary injury mechanisms.
Main Results:
- Optimism for more effective ICH therapies due to improved understanding and technology.
- Potential for minimally invasive surgery and thrombolytics to manage hematoma.
- Advanced imaging can guide coagulopathy reversal and hemostatic therapy.
Conclusions:
- Future ICH treatment may involve a combination of minimally invasive surgery, advanced imaging for patient selection, ultra-early diagnosis, and novel drugs targeting secondary injury.
- Targeting inflammatory cascades, edema, and hemoglobin toxicity shows promise.
Opinion Statement:
The mortality and morbidity from intracerebral hemorrhage (ICH) remain high despite advances in medical, neurologic, and surgical care during the past decade. The lessons learned from previous therapeutic trials in ICH, improved understanding of the pathophysiology of neuronal injury after ICH, and advances in imaging and pre-hospital assessment technologies provide optimism that more effective therapies for ICH are likely to emerge in the coming years. The potential new avenues for the treatment of ICH include a combination of increased utilization of minimally invasive surgical techniques with or without thrombolytic usage to evacuate or reduce the size of the hematoma; utilization of advanced imaging to improve selection of patients who are likely to benefit from reversal of coagulopathy or hemostatic therapy; ultra-early diagnosis and initiation of therapy in the ambulance; and the use of novel drugs to target the secondary injury mechanisms, including the inflammatory cascade, perihematomal edema reduction, and hemoglobin degradation products-mediated toxicity.
Related Concept Videos
01:29Hemorrhagic Stroke ll: Pathophysiology
01:17Hemorrhagic Stroke l: Introduction
01:29Venous Thrombosis III: Interprofessional Care